Modified release formulations containing drug-ion exchange resin complexes

Details for Australian Patent Application No. 2007227569 (hide)

Owner Tris Pharma, Inc.

Inventors Mehta, Ketan; Tu, Yu-Hsing

Agent Davies Collison Cave

Pub. Number AU-A-2007227569

PCT Pub. Number WO2007/109104

Priority 60/783,181 16.03.06 US

Filing date 15 March 2007

Wipo publication date 27 September 2007

International Classifications

A61K 9/58 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

9 October 2008 PCT application entered the National Phase

  PCT publication WO2007/109104 Priority application(s): WO2007/109104

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007227570-Flavivirus inhibition by sultams and related compounds

2007227564-New process of making biomaterials